SG46307A1 - New pyrazine derivatives the preparation and use thereof - Google Patents
New pyrazine derivatives the preparation and use thereofInfo
- Publication number
- SG46307A1 SG46307A1 SG1996002613A SG1996002613A SG46307A1 SG 46307 A1 SG46307 A1 SG 46307A1 SG 1996002613 A SG1996002613 A SG 1996002613A SG 1996002613 A SG1996002613 A SG 1996002613A SG 46307 A1 SG46307 A1 SG 46307A1
- Authority
- SG
- Singapore
- Prior art keywords
- preparation
- pyrazine derivatives
- new pyrazine
- new
- compounds
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/10—Antioedematous agents; Diuretics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
- C07D241/02—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
- C07D241/10—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
- C07D241/14—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D241/24—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D241/26—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with nitrogen atoms directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Urology & Nephrology (AREA)
- Endocrinology (AREA)
- Hematology (AREA)
- Vascular Medicine (AREA)
- Diabetes (AREA)
- Reproductive Health (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Plural Heterocyclic Compounds (AREA)
- Liquid Crystal Substances (AREA)
- Apparatus Associated With Microorganisms And Enzymes (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE4127026A DE4127026A1 (de) | 1991-08-16 | 1991-08-16 | Neue pyrazinderivate, ihre herstellung und verwendung |
| DE19914130461 DE4130461A1 (de) | 1991-09-13 | 1991-09-13 | Neue pyrazinderivate, ihre herstellung und verwendung |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SG46307A1 true SG46307A1 (en) | 1998-02-20 |
Family
ID=25906394
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG1996002613A SG46307A1 (en) | 1991-08-16 | 1992-07-31 | New pyrazine derivatives the preparation and use thereof |
Country Status (22)
Families Citing this family (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6645969B1 (en) | 1991-05-10 | 2003-11-11 | Aventis Pharmaceuticals Inc. | Aryl and heteroaryl quinazoline compounds which inhibit CSF-1R receptor tyrosine kinase |
| IL109570A0 (en) * | 1993-05-17 | 1994-08-26 | Fujisawa Pharmaceutical Co | Guanidine derivatives, pharmaceutical compositions containing the same and processes for the preparation thereof |
| DE4325822A1 (de) * | 1993-07-31 | 1995-02-02 | Hoechst Ag | Substituierte Benzoylguanidine, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament |
| US5852046A (en) * | 1993-08-03 | 1998-12-22 | Hoechst Aktiengesellschaft | Benzo-fused heterocyclic compounds having a 5-membered ring processes for their preparation their use as medicaments their use as diagnostic agents and medicaments containing them |
| DE4337609A1 (de) * | 1993-11-04 | 1995-05-11 | Boehringer Ingelheim Kg | Neue Pyrazincarboxamidderivate, ihre Herstellung und ihre Verwendung in Arzneimitteln |
| DE4412334A1 (de) * | 1994-04-11 | 1995-10-19 | Hoechst Ag | Substituierte N-Heteroaroylguanidine, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament |
| US5760230A (en) * | 1996-10-11 | 1998-06-02 | Bayer Aktiengesellschaft | 4, 4'-bridged bis-2, 4-diaminoquinazolines |
| US6420354B1 (en) * | 1998-06-08 | 2002-07-16 | Advanced Medicine, Inc. | Sodium channel drugs and uses |
| IT1312310B1 (it) * | 1999-05-07 | 2002-04-15 | Recordati Ind Chimica E Farma | Uso di antagonisti selettivi del recettore adrenergico a 1b per ilmiglioramento della disfunzione sessuale |
| WO2000075115A1 (fr) | 1999-06-03 | 2000-12-14 | Takeda Chemical Industries, Ltd. | Preparations s'administrant par voie nasale |
| US6479498B1 (en) | 1999-06-04 | 2002-11-12 | Theravance, Inc. | Sodium channel drugs and uses |
| US6156758A (en) * | 1999-09-08 | 2000-12-05 | Isis Pharmaceuticals, Inc. | Antibacterial quinazoline compounds |
| EP1485099B1 (en) * | 2002-03-13 | 2010-07-07 | Janssen Pharmaceutica N.V. | Inhibitors of histone deacetylase |
| WO2006074147A2 (en) | 2005-01-03 | 2006-07-13 | Myriad Genetics, Inc. | Nitrogen containing bicyclic compounds and therapeutical use thereof |
| US8309562B2 (en) | 2003-07-03 | 2012-11-13 | Myrexis, Inc. | Compounds and therapeutical use thereof |
| AU2004253967B2 (en) | 2003-07-03 | 2010-02-18 | Cytovia, Inc. | 4-arylamino-quinazolines as activators of caspases and inducers of apoptosis |
| US20070238740A1 (en) | 2003-08-28 | 2007-10-11 | Nitromed, Inc. | Nitrosated And Nitrosylated Cardiovascular Compounds, Compositions And Methods Of Use |
| US8258145B2 (en) | 2005-01-03 | 2012-09-04 | Myrexis, Inc. | Method of treating brain cancer |
| AU2006216665A1 (en) | 2005-02-24 | 2006-08-31 | Nicox S.A. | Nitric oxide enhancing diuretic compounds, compositions and methods of use |
| DE102008061247A1 (de) | 2008-12-10 | 2010-06-24 | Christian-Albrechts-Universität Zu Kiel | Inhibitoren der Dimethylarginin Dimethylaminohydrolase |
| JP5695200B2 (ja) * | 2010-09-10 | 2015-04-01 | ハンジョウ ベンシェン ファーマシューティカル シーオー．， エルティーディー．Ｈａｎｇｚｈｏｕ Ｂｅｎｓｈｅｎｇ Ｐｈａｒｍａｃｅｕｔｉｃａｌ Ｃｏ．， Ｌｔｄ． | 複素環アミノベルバミン誘導体、その調製方法及び使用 |
| CN110041291B (zh) * | 2018-01-15 | 2021-02-26 | 北京采瑞医药科技研究院有限公司 | 一种玛咖酰胺衍生物及其制备方法 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BE639386A (enrdf_load_stackoverflow) * | 1962-10-30 | |||
| US3527758A (en) * | 1967-04-13 | 1970-09-08 | Merck & Co Inc | Process for the preparation of pyrazinoylguanidines from a pyrazinoic azide and a guanidine |
| US3539569A (en) * | 1968-08-21 | 1970-11-10 | Merck & Co Inc | Preparation of pyrazinoylguanidines from pyrazinoylureas |
| NL7803906A (nl) * | 1978-04-12 | 1979-10-16 | Noordvos Schroeven Bv | Werkwijze, inrichting en propeller voor het verdelen van een gasvormig, poedervormig of vloeibaar materiaal in een vloeistof. |
| GB8712365D0 (en) * | 1987-05-26 | 1987-07-01 | Ici America Inc | Aminomethylphenolic pyrazines |
-
1992
- 1992-07-28 TW TW081105973A patent/TW213903B/zh active
- 1992-07-31 RU RU94015265A patent/RU2124008C1/ru active
- 1992-07-31 AU AU23870/92A patent/AU669122B2/en not_active Ceased
- 1992-07-31 CZ CZ94337A patent/CZ280760B6/cs unknown
- 1992-07-31 ES ES92916697T patent/ES2108129T3/es not_active Expired - Lifetime
- 1992-07-31 FI FI940696A patent/FI940696A7/fi unknown
- 1992-07-31 SG SG1996002613A patent/SG46307A1/en unknown
- 1992-07-31 CA CA002115755A patent/CA2115755A1/en not_active Abandoned
- 1992-07-31 DK DK92916697.3T patent/DK0598770T3/da active
- 1992-07-31 WO PCT/EP1992/001738 patent/WO1993004048A1/de active IP Right Grant
- 1992-07-31 AT AT92916697T patent/ATE159250T1/de not_active IP Right Cessation
- 1992-07-31 HU HU9400430A patent/HUT67661A/hu unknown
- 1992-07-31 EP EP92916697A patent/EP0598770B1/de not_active Expired - Lifetime
- 1992-07-31 SK SK175-94A patent/SK17594A3/sk unknown
- 1992-07-31 DE DE59208974T patent/DE59208974D1/de not_active Expired - Fee Related
- 1992-07-31 JP JP5504057A patent/JPH06509798A/ja active Pending
- 1992-08-11 MX MX9204637A patent/MX9204637A/es not_active IP Right Cessation
- 1992-08-14 NZ NZ243959A patent/NZ243959A/en unknown
- 1992-08-14 IL IL102814A patent/IL102814A0/xx unknown
- 1992-08-17 IE IE259292A patent/IE922592A1/en not_active IP Right Cessation
-
1994
- 1994-02-15 NO NO940523A patent/NO301542B1/no unknown
-
1997
- 1997-12-23 GR GR970403392T patent/GR3025742T3/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| FI940696L (fi) | 1994-02-15 |
| HU9400430D0 (en) | 1994-05-30 |
| AU669122B2 (en) | 1996-05-30 |
| AU2387092A (en) | 1993-03-16 |
| SK17594A3 (en) | 1994-12-07 |
| IL102814A0 (en) | 1993-01-31 |
| RU2124008C1 (ru) | 1998-12-27 |
| DE59208974D1 (de) | 1997-11-20 |
| NO301542B1 (no) | 1997-11-10 |
| NO940523L (no) | 1994-02-15 |
| EP0598770B1 (de) | 1997-10-15 |
| TW213903B (enrdf_load_stackoverflow) | 1993-10-01 |
| HK1003137A1 (en) | 1998-10-09 |
| NO940523D0 (no) | 1994-02-15 |
| EP0598770A1 (de) | 1994-06-01 |
| GR3025742T3 (en) | 1998-03-31 |
| FI940696A0 (fi) | 1994-02-15 |
| IE922592A1 (en) | 1993-02-24 |
| JPH06509798A (ja) | 1994-11-02 |
| CZ280760B6 (cs) | 1996-04-17 |
| CA2115755A1 (en) | 1993-03-04 |
| FI940696A7 (fi) | 1994-02-15 |
| RU94015265A (ru) | 1997-02-20 |
| ES2108129T3 (es) | 1997-12-16 |
| CZ33794A3 (en) | 1994-07-13 |
| DK0598770T3 (da) | 1997-12-15 |
| ATE159250T1 (de) | 1997-11-15 |
| MX9204637A (es) | 1993-02-01 |
| NZ243959A (en) | 1995-07-26 |
| HUT67661A (en) | 1995-04-28 |
| WO1993004048A1 (de) | 1993-03-04 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| SG46307A1 (en) | New pyrazine derivatives the preparation and use thereof | |
| IL76457A0 (en) | Tetralin derivatives,their preparation and pharmaceutical compositions containing them | |
| ZA948669B (en) | New pyrazine carboxamide derivatives the preparation thereof and their use in pharmaceutical compositions | |
| PT83647A (en) | Process for the preparation of novel pharmaceutical benzimidazole derivatives and of pharmaceutical compositions containing the same | |
| IL109526A0 (en) | Benzofuranyl- and thiophenyl-alkanecarboxylic acid derivatives, their preparation and pharmaceutical compositions containing them | |
| AU2724292A (en) | Antiviral 4-substituted-2-deoxy-2,3-didehydro-derivatives of alpha-d-neuraminic acid | |
| IE873125L (en) | Benzimidazole derivatives | |
| HU906007D0 (en) | Process for the preparation of pyrimidine-4,6-dicarbonic acid-diamides and medical preparations containing them as active agents | |
| AU611113B2 (en) | Basically substituted phenylacetonitriles, their preparation and drugs containing these compounds | |
| IL69683A0 (en) | Isoquinoline derivatives,a process for their preparation,pharmaceutical formulations based on these compounds and the use thereof | |
| HU895241D0 (en) | Process for the preparation of substituted 1,3,5-triazin-trione derivatives and pharmaceutical compositions containing said compounds as active ingredient | |
| AU629445B2 (en) | Improvements in or relating to topical compositions containing 1 alpha 25-dihydroxycholecalciferol | |
| NZ220800A (en) | Tetrahydrobenzothiazoles and pharmaceutical compositions | |
| CA2119661A1 (fr) | Nouveaux composes de n-benzylpiperazine, leur procede de preparation et les compositions pharmaceutiques les renfermant | |
| HUT57227A (en) | 2'-dezamino-4'-desoxy-4'-amino-8-fluoro-anthracycline derivatives, process for producing them as well as pharmaceutical preparatives containing said compounds as active substance | |
| AU641950B2 (en) | (1R,2R)-2-(3-pyridyl)-tetrahydrothiopyran-2-carbothioamide 1-oxides, process for their preparation and pharmaceutical compositions containing them | |
| HUT54682A (en) | Process for producing 13-bromine- and 13,14-dibromine-ergoline derivatives and pharmaceutical preparatives containing these compounds | |
| IL100128A0 (en) | Pharmaceutical compositions containing an imidazobenzodiazepine | |
| HU901631D0 (en) | Process for the preparation of thienyl-piperazine derivatives and pharmaceutical compositions containing them | |
| HUT60495A (en) | Process for producing ergoline derivatives and pharmaceutical compositions comprising such compounds | |
| IT1254256B (it) | Derivati di idroisochinolina | |
| ZA879578B (en) | Dibenzo(be)oxepinacetic acid derivatives,their preparation and pharmaceutical compositions containing them |